mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD). (Q45394627)
Jump to navigation
Jump to search
scientific article published in August 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD). |
scientific article published in August 2008 |
Statements
1 reference
mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD). (English)
1 reference
Clive S Zent
1 reference
Shernan G Holtan
1 reference
Luis F Porrata
1 reference
Joseph P Colgan
1 reference
Thomas M Habermann
1 reference
Svetomir N Markovic
1 reference
1 August 2008
1 reference
1 reference
Identifiers
1 reference